Development and validation of RAYDOSE: A Geant4-based application for molecular radiotherapy

Physics in Medicine and Biology

Volumn 58, Issue 8, 2013, Pages 2491-2508

  Marcatili, S ^a,d   Pettinato, C ^b   Daniels, S ^a   Lewis, G ^c   Edwards, P ^a   Fanti, S ^b   Spezi, E ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c VELINDRE CANCER CENTRE   (United Kingdom)

^d CANCER RESEARCH CENTER OF TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EXPERIMENTAL MEASUREMENTS; MEASUREMENTS OF; MONTE CARLO SIMULATIONS; MULTI-MODALITY; PATIENT GEOMETRIES; PATIENT SPECIFIC; REFERENCE DATA; TREATMENT PLANNING;

COMPUTERIZED TOMOGRAPHY; MONTE CARLO METHODS;

PATIENT TREATMENT;

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; IMAGE QUALITY; METHODOLOGY; MONTE CARLO METHOD; PERSONALIZED MEDICINE; RADIATION DOSE; THREE DIMENSIONAL IMAGING; VALIDATION STUDY;

HUMANS; IMAGING, THREE-DIMENSIONAL; INDIVIDUALIZED MEDICINE; MONTE CARLO METHOD; PHANTOMS, IMAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84875959505     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/58/8/2491     Document Type: Article

References (48)

1. Agostinelli S et al 2003 Geant4: a simulation toolkit Nucl. Instrum. Methods 506 250-303
2. Amerio S et al 2004 Dosimetric characterization of a large area pixel-segmented ionization chamber Med. Phys. 31 414-20
3. Arce P, Apostolakis J and Cosmo G 2008 A technique for optimised navigation in regular geometries IEEE Nuclear Science Symp. Conf. Record pp 857-9
4. Bardiès M et al 2011 Dosimetry of radionuclide therapy IPEM Report 104 (York: Institute of Physics and Engineering in Medicine)
5. Bolch W E, Eckerman K F, Sgourous G and Thomas S R 2009 MIRD Pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry - standardization of nomenclature 2009 J. Nucl. Med. 50 477-84
6. Bolch W E et al 1999 MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions - radionuclide S values at the voxel level J. Nucl. Med. 40 11-36S
7. Botta F et al 2011 Calculation of electron and isotopes dose point kernels with FLUKA Monte Carlo code for dosimetry in nuclear medicine therapy Med. Phys. 38 3944-54
8. Brun R and Rademakers F 1997 ROOT - an object oriented data analysis framework Nucl. Instrum. Methods Phys. Res. A 389 81-86
9. Chauvie S et al 2004 Geant4 low energy electromagnetic physics IEEE Nuclear Science Symp. Conf. Record pp 1881-5
10. Chiavassa S, Aubineau- Lanièce I, Bitar A, Ferrer L, Lisbona A, Franck D, Jourdain J R and Bardiès M 2006a Validation par la mesure d' OEDIPE, outil d'évaluation de la dose interne personnalisée Radioprotection 41 401-11 (in French)
11. Chiavassa S, Aubineau-Lanice I, Bitar A, Lisbona A, Barbet J, Franck D, Jourdain J R and Bardiès M 2006b Validation of a personalized dosimetric evaluation tool (Oedipe) for targeted radiotherapy based on the Monte Carlo MCNPX code Phys. Med. Biol. 51 601-16
12. Chiesa C, Botta F, Coliva A, Maccauro M, Devizzi L, Guidetti A, Carlo-Stella C, Seregni E, Gianni M A and Bombardieri E 2009 Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin) Eur. J. Nucl. Med. Mol. Imaging 36 1745-57
13. Cramer H 1999 Mathematical Methods of Statistics (Princeton, NJ: Princeton University Press)
14. Cullen D et al 1997 The evaluated photon data library Technical Report UCRL-50400 vol 6
15. Deasy J O, Blanco A I and Clark V H 2003 CERR: a computational environment for radiotherapy research Med. Phys. 30 979-85
16. Dewaraja Y K, Frey E C, Sgouros G, Brill A B, Roberson P, Zanzonico P B and Ljungberg M 2012 MIRD Pamphlet No. 23: Quantitative SPECT for patient-specific 3 dimensional dosimetry in internal radionuclide therapy J. Nucl. Med. 53 1310-25
17. 131I-Tositumomab radioimmunotherapy: initial tumor dose response results using 3-dimensional dosimetry including radiobiologic modeling J. Nucl. Med. 51 1155-62
18. Dewaraja Y K, Wilderman S J, Ljungberg M, Koral K F, Zasadny K and Kaminiski M S 2005 Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation J. Nucl. Med. 46 840-9
19. Dieudonné A, Hobbs R F, Bolch W E, Sgouros G and Gardin I 2010 Fine-resolution voxel S values for constructing absorbed dose distributions at variable voxel size J. Nucl. Med. 51 1600-7
20. Flux G, Moss L, Buscombe J, Gaze M, Guy M, Mather S and Orchard K 2011 Molecular Radiotherapy in the UK: Current Status and Recommendations for Further Investigation - BIR Report 23 (London: British Institute of Radiology) ISBN-13: 9780905749709 (ISBN-10: 0905749707)
21. Flux G D, Guy M J, Beddows R, Pryor M and Flower M A 2002 Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy Phys. Med. Biol. 47 3211-23
22. Furhang E E, Chui C S, Kolbert K S, Larson S M and Sgouros G 1997 Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy Med. Phys. 24 1163-72
23. Gear J I, Charles-Edwards E, Partridge M and Flux G D 2011 Monte Carlo verification of polymer gel dosimetry applied to radionuclide therapy: a phantom study Phys. Med. Biol. 56 7273-86
24. Hobbs R F, Wahl R L, Lodge M A, Javadi M S, Cho S Y, Chien D T, Ewertz M E, Esaias C E, Ladenson P W and Sgouros G 2009 124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison J. Nucl. Med. 50 1844-7
25. ICRU 1992 Photon, electron, proton and neutron interaction data for body tissues ICRU Report 46
26. ICRU 1999 Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50) ICRU Report 62
27. Jan S et al 2004 GATE: a simulation toolkit for PET and SPECT Phys. Med. Biol. 49 4543-61
28. Knoop B O, Geworski L, Hofmann M, Munz D L and Knapp W H 2002 Use of recovery coefficients as a test of system linearity of response in positron emission tomography (PET) Phys. Med. Biol. 47 1237-54
29. Lanconelli N, Pacilio M, Lo Meo S, Botta F, Di Dia A, Torres Aroche L A, Coca Pérez M A and Cremonesi M 2012 A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions Phys. Med. Biol. 57 517-33
30. Lehmann J et al 2005 Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system Phys. Med. Biol. 50 947-58
31. Meredith R, Wessels B and Knox S 2008 Risks to normal tissues from radionuclide therapy Semin. Nucl. Med. 38 347-57
32. Mohan R 1997 Why Monte Carlo? Proc. 12th Int. Conf. on the Use of Computers in Radiation Therapy (Salt Lake City, Utah,) ed D D Leavitt and D Starkschall (Madison, WI: Medical Physics Publishing) pp 16-18
33. NEMA 2011 Digital Imaging and Communications in Medicine (DICOM) (Rosslyn, VA: National Electrical Manufacturers Association)
34. Pacilio M, Lanconelli N, Lo M S, Betti M, Montani L, Torres A L and Coca P M 2009 Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations Med. Phys. 36 1543-52
35. Papadimitroulas P, Loudos G, Nikiforidis G C and Kagadisa G C 2012 A dose point kernel database using GATE Monte Carlo simulation toolkit for nuclear medicine applications: Comparison with other Monte Carlo codes Med. Phys. 39 5238-47
36. Perkins S T et al 1991a Tables and graphs of electron-interaction cross-sections from 10 eV to 100 GeV derived from the LLNL evaluated electron data library (EEDL), Z = 1-100 Lawrence Livermore National Laboratory Report UCRL-50400 vol 31
37. Perkins S T et al 1991b Tables and graphs of atomic subshell and relaxation data derived from the LLNL evaluated atomic data library (EADL), Z = 1-100 Lawrence Livermore National Laboratory Report UCRL-50400 vol 30
38. Prideaux A R, Song H, Hobbs R F, He B, Frey E C, Ladenson P W, Wahl R L and Sgouros G 2007 Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imagingbased internal dosimetry J Nucl. Med. 48 1008-16
39. Sarfaraz M, Kennedy A S, Lodge M A, Li X A, Wu X and Yu C X 2004 Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma Med. Phys. 31 2499-53
40. Sgouros G, Hobbs R F, Atkins F B, Van Nostrand D, Ladenson P W and Wahl R L 2011 Three-dimensional radiobiological dosimetry (3DRD) with 124I PET for 131I therapy of thyroid cancer Eur. J. Nucl. Med. Mol. Imaging 38 S41-47
41. Song H, He B, Prideaux A, Du Y, Frey E, Kasecamp W, Ladenson P W, Wahl R W and Sgouros G 2006 Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases J. Nucl. Med. 47 1985-94
42. Soret M, Bacharach S L and Buvat I 2007 Partial-Volume Effect in PET Tumor Imaging J. Nucl. Med. 48 932-45
43. Stabin M G 2007 Uncertainties in Internal Dose Calculations for Radiopharmaceuticals J. Nucl. Med. 49 853-60
44. Stabin M G, Sparks R B and Crowe E 2005 OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine J. Nucl. Med. 46 1023-7
45. Tsougos I, Loudos G, Georgoulias P, Theodorou K and Kappas C 2010 Patient-specific internal radionuclide dosimetry Nucl. Med. Commun. 31 97-106
46. Tuli J et al 1987 Evaluated nuclear structure data file BNL-NCS-51655-Rev87
47. Wilderman S J and Dewaraja Y K 2007 Method for fast CT/SPECT-Based 3D Monte Carlo absorbed dose computations in internal emitter therapy IEEE Trans. Nucl. Sci. 54 146-51
48. Yoriyaz H, Stabin M G and dos Santos A 2001 Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry J. Nucl. Med. 42 662-9